Literature DB >> 1884549

Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors.

N Araki1, A Uchida, T Kimura, H Yoshikawa, Y Aoki, T Ueda, S Takai, T Miki, K Ono.   

Abstract

The retinoblastoma (Rb) gene, thought by some to be associated with tumor formation of retinoblastoma as a recessive human oncogene, was investigated in 57 cases using DNA and RNA from primary osteosarcomas and other bone and soft-tissue tumors. Eight of 23 osteosarcoma cases (35%) showed structural alterations of the Rb gene. Three of the eight demonstrated homozygous deletions, and the remaining five cases showed heterozygous deletions. Seven out of eight cases represented deletion of a 7.5-kb HindIII fragment. Northern blot analysis of five cases of osteosarcoma showed that four demonstrated no detectable Rb gene transcription, and one case had a truncated 3.5-kb fragment with a faint 4.7-kb band. In the other 34 cases of bone and soft-tissue tumors, two cases of three malignant fibrous histiocytomas showed an Rb gene abnormality by Southern blot analysis. These results strongly suggest that Rb gene alteration is pertinent to the tumorigenesis of most osteosarcoma cases and some other bone and soft-tissue tumors.

Entities:  

Mesh:

Year:  1991        PMID: 1884549

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  20 in total

1.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

2.  THE RETINOBLASTOMA PROTEIN: A MASTER TUMOR SUPPRESSOR ACTS AS A LINK BETWEEN CELL CYCLE AND CELL ADHESION.

Authors:  B E Engel; W D Cress; P G Santiago-Cardona
Journal:  Cell Health Cytoskelet       Date:  2014-12-18

3.  Biomarkers in Osteosarcoma.

Authors:  Colin Kong; Marc F Hansen
Journal:  Expert Opin Med Diagn       Date:  2009-01-01

4.  Alterations of the p53, Rb and MDM2 genes in osteosarcoma.

Authors:  C W Miller; A Aslo; A Won; M Tan; B Lampkin; H P Koeffler
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 5.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

6.  Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone.

Authors:  Y Ueda; B Dockhorn-Dworniczak; S Blasius; W Mellin; P Wuisman; W Böcker; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 7.  Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

Authors:  James J Morrow; Chand Khanna
Journal:  Crit Rev Oncog       Date:  2015

8.  The Current and Future Therapies for Human Osteosarcoma.

Authors:  Joseph D Lamplot; Sahitya Denduluri; Jiaqiang Qin; Ruidong Li; Xing Liu; Hongyu Zhang; Xiang Chen; Ning Wang; Abdullah Pratt; Wei Shui; Xiaoji Luo; Guoxin Nan; Zhong-Liang Deng; Jinyong Luo; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Curr Cancer Ther Rev       Date:  2013-02

9.  CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.

Authors:  G P Nielsen; K L Burns; A E Rosenberg; D N Louis
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

10.  Defective osteogenic differentiation in the development of osteosarcoma.

Authors:  Eric R Wagner; Gaurav Luther; Gaohui Zhu; Qing Luo; Qiong Shi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Yanhong Gao; Ke Yang; Linyuan Wang; Chad Teven; Xiaoji Luo; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Yang Bi; Bai-Cheng He; Ni Tang; Jinyong Luo; Liang Chen; Guowei Zuo; Richard Rames; Rex C Haydon; Hue H Luu; Tong-Chuan He
Journal:  Sarcoma       Date:  2011-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.